View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Informations sur les droits de vote et les actions au 30 avril 2025

Informations sur les droits de vote et les actions au 30 avril 2025 Le 9 mai 2025 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Date Nombre total d’actions composant le capital social Nombre total de droits de vote Total brut (1) Total net (2) 30/04/2025 130 848 866 143 648 674 143 648 674         Le nom...

Alicia Reese ... (+4)
  • Alicia Reese
  • Kade Barr
  • Matthew McCartney
  • Michael Pachter
 PRESS RELEASE

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - avril ...

GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - avril 2025 Raison sociale de l'émetteur :BNP PARIBAS - SA au capital de 2.261.621.342 eurosImmatriculée sous le n° 662 042 449 RCS Paris Siège social : 16, boulevard des Italiens, 75009 Paris  Informations relatives au nombre total de droits de vote et d'actions prévues parl'article L.233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des Marchés Financiers          Date Nombre d'actions composant le capital    Nombre total de droits de vote          30 avril 20251 130 810 6711 130 810 67...

Cedric Rossi ... (+3)
  • Cedric Rossi
  • Clement Genelot
  • Loic Morvan

On the shelves now: Consumer Weekly #68

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at fragile US consumer sentiment which might precede a sharp pullback in spe

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.
 PRESS RELEASE

BNP PARIBAS SA: Disclosure for G-SIIs indicators as of 31 December 202...

BNP PARIBAS SA: Disclosure for G-SIIs indicators as of 31 December 2024 Paris, 30 April 2025 Global systemically important institutions (G-SIIs) indicators for BNP Paribas Group as of 31 December 2024 are presented hereafter according to European Banking Authority (EBA) Implementing Technical Standards. The Basel Committee on Banking Supervision (BCBS) assesses the systemic importance of banks in a global context. The measurement approach of the global systemic importance is indicator-based. The methodology is outlined in “Global systemically important banks: updated assessment methodolo...

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/28/2025

Isabel Marant: improving Q4 results (main takeways)|Verallia: the board of directors issues a favourable opinion on the takeover bid|Mediobanca bids €6.3 bn for Banca Generali|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 28/04/2025

Isabel Marant : résultats T4 supérieurs aux attentes (premiers éléments)|Verallia : le conseil d’administration émet un avis favorable à l’offre de rachat|Mediobanca lance une offre à 6.3 mds EUR sur Banca Generali|

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould
Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould
Clement Genelot
  • Clement Genelot

Carrefour: soft start to the year in France

Q1 was a soft start to the year with 0.6% LfL excl. Argentina, slightly below expectations mostly driven by France where price elasticity of 2024 price investments remains limited. We expect no material css adjustments and stick to our recent Sell rating. Upcoming court rulings over May-June will b

 PRESS RELEASE

BNP PARIBAS GROUP : RELEASE OF THE 1ST AMENDMENT TO THE ENGLISH VERSIO...

BNP PARIBAS GROUP : RELEASE OF THE 1ST AMENDMENT TO THE ENGLISH VERSION OF THE UNIVERSAL REGISTRATION DOCUMENT AND ANNUAL FINANCIAL REPORT 2024 RELEASE OF THE 1st AMENDMENT TO THE ENGLISH VERSION OF THE UNIVERSAL REGISTRATION DOCUMENT AND ANNUAL FINANCIAL REPORT 2024 PRESS RELEASE Paris, 24 April 2025 BNP Paribas announces the publication of the 1st amendment to the English version of the Universal registration document and Annual financial report 2024. This amendment was filed with the Autorité des Marchés Financiers (AMF) on 24 April 2025 and is listed under n° D.25-0122-A01. The doc...

 PRESS RELEASE

GROUPE BNP PARIBAS : MISE A DISPOSITION DU 1ER AMENDEMENT AU DOCUMENT ...

GROUPE BNP PARIBAS : MISE A DISPOSITION DU 1ER AMENDEMENT AU DOCUMENT D’ENREGISTREMENT UNIVERSEL ET RAPPORT FINANCIER ANNUEL 2024 MISE À DISPOSITION DU 1er AMENDEMENT AU DOCUMENT D’ENREGISTREMENT UNIVERSEL ET RAPPORT FINANCIER ANNUEL 2024 COMMUNIQUÉ DE PRESSE Paris, le 24 avril 2025 BNP Paribas annonce que le premier amendement au Document d’enregistrement universel et Rapport financier annuel 2024 en langue française a été publié. Cet amendement a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 24 avril 2025 sous le n° D.25-0121-A01. Ce document est disponible sur le...

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/24/2025

French retail sales down 2.4% in March + Q1 update|Fnac Darty: decent Q1 sales, strong performance in Southern Europe, guidance confirmed.|Saipem: good set of Q1 2025 results|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch